Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Sarepta Therapeutics To Rally Over 53%? Here Are 10 Other Analyst Forecasts For Wednesday
March 01, 2023
Tickers
AAP
AMBA
BLDR
HPQ
Tags
SRPT
analyst forecasts
Small Cap
From
Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
March 01, 2023
Tickers
AMC
BILI
BMR
BRSP
Tags
GROV
Market News
BILI
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 01, 2023
Tickers
BGS
BMR
BRSP
CBIO
Tags
SRPT
MLSS
Today's Market
From
InvestorPlace
Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript
February 28, 2023
Tickers
SRPT
Tags
Market News
SRPT
Recent Press Releases
From
Motley Fool
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
SPX
SRPT
JP:4523
From
MarketWatch
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Tickers
BLPH
CBIO
CPHI
CUTR
Tags
WORX
SRPT
Benzinga
From
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Tickers
NFE
NNI
NRDY
NSTG
Tags
REAL
OSPN
NTRA
From
Benzinga
Expert Ratings for Sarepta Therapeutics
February 15, 2023
Tickers
SRPT
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
Tickers
CRSP
GNOM
MYGN
NTLA
Tags
NTLA
Stocks to Buy
NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:NTLA,NASDAQ:MYGN,NASDAQ:SRPT
From
InvestorPlace
9 Analysts Have This to Say About Sarepta Therapeutics
January 20, 2023
Tickers
SRPT
Tags
SRPT
Analyst Ratings
Market News
From
Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Tickers
ABBV
CRSP
CVAC
DIS
Tags
ABBV
DIS
CRSP
From
InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
Tickers
CRSP
SRPT
VRTX
Tags
SRPT
Market News
VRTX
From
Motley Fool
BTIG Maintains Buy Rating for Sarepta Therapeutics: Here's What You Need To Know
December 22, 2022
Tickers
SRPT
Tags
SRPT
Market News
Analyst Ratings
From
Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
Tickers
AZN
GH
SRPT
Tags
Recent Press Releases
SRPT
AZN
From
Motley Fool
Analyst Ratings for Sarepta Therapeutics
November 03, 2022
Tickers
SRPT
Tags
Analyst Ratings
Market News
SRPT
From
Benzinga
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
November 03, 2022
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Earnings Scheduled For November 2, 2022
November 02, 2022
Tickers
QMCO
QRVO
RACE
RARE
Tags
RUN
SIGI
WES
From
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
Tickers
DNA
NVCR
SRPT
Tags
NVCR
Recent Press Releases
Market News
From
Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
October 19, 2022
Tickers
CRSP
SRPT
Tags
Market News
SRPT
CRSP
From
Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
October 17, 2022
Tickers
AAPL
BILL
LIN
OPEN
Tags
Markets
BILL
Pre/Market Outlook
From
Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
October 13, 2022
Tickers
SRPT
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
September 28, 2022
Tickers
PEPG
SRPT
Tags
Trading Ideas
PEPG
Benzinga
From
Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
September 16, 2022
Tickers
CNA
COIN
SRPT
Tags
News
COIN
SRPT
From
Benzinga
Analyst Ratings for Sarepta Therapeutics
September 08, 2022
Tickers
SRPT
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
September 08, 2022
Tickers
SRPT
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
Tags
Market News
Benzinga
FDA
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
August 29, 2022
Tickers
CRSP
MYGN
SRPT
Tags
MYGN
SRPT
Market News
From
Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
August 08, 2022
Tickers
SRPT
Tags
Contracts
News
Briefs
From
Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
August 08, 2022
Tickers
SRPT
Tags
Market News
Analyst Ratings
Media
From
Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
August 03, 2022
Tickers
SRPT
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.